Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024PRNewsWire • 04/17/24
Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewPRNewsWire • 02/28/24
Will Nevro (NVRO) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 02/14/24
Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic NeuropathyPRNewsWire • 02/01/24
Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024PRNewsWire • 01/29/24
Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic NeuropathyPRNewsWire • 01/18/24
Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual MeetingPRNewsWire • 01/17/24